Randomised trial to evaluate the efficacy of inhibition of either JAK1/2 or complement activation in severe COVID-19

Hall, Frances, Cheriyan, Joseph, Cope, Andrew P., Galloway, James, Wilkinson, Ian, Bond, Simon, Norton, Sam, Banham-Hall, Edward, Bayes, Hannah, Kostapanos, Michalis, Nodale, Marianna, Petchey, William, Sheeran, Thomas, Underwood, Jonathan ORCID: https://orcid.org/0000-0001-6963-2821 and Jayne, David R. 2023. Randomised trial to evaluate the efficacy of inhibition of either JAK1/2 or complement activation in severe COVID-19. The Lancet Respiratory Medicine Item availability restricted.

PDF - Accepted Post-Print Version Restricted to Repository staff only until 20 September 2024 due to copyright restrictions. Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (358kB)

Item Type:	Article
Date Type:	Published Online
Status:	In Press
Schools:	Medicine
Publisher:	Elsevier
ISSN:	2213-2600
Date of First Compliant Deposit:	25 October 2023
Date of Acceptance:	20 September 2023
Last Modified:	10 Nov 2023 16:15
URI:	https://orca.cardiff.ac.uk/id/eprint/163225

Actions (repository staff only)

Edit Item